Use of COVID-19 Convalescent Plasma for Treatment of Symptomatic SARS-CoV-2 Infection at a Children's Hospital: A Contribution to a Still Inadequate Body of Evidence

• मुख्य लेखकों: Antonio Arrieta (लेखक), Alvaro E. Galvis (लेखक), Stephanie Osborne (लेखक), Tricia Morphew (लेखक), Karen Imfeld (लेखक), Claudia Enriquez (लेखक), Janet Hoang (लेखक), Marcia Swearingen (लेखक), Delma J. Nieves (लेखक), Negar Ashouri (लेखक), Jasjit Singh (लेखक), Diane Nugent (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: MDPI AG, 2023-02-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Data on COVID-19 convalescent plasma (CCP) safety and efficacy in children and young adults are limited. This single-center prospective, open-label trial evaluates CCP safety, neutralizing antibody kinetics, and outcomes in children and young adults with moderate/severe COVID-19 (April 2020-March 20...